Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific seeks closure

This article was originally published in The Gray Sheet

Executive Summary

Company becomes exclusive worldwide distributor of Therus' vascular closure products and will make an equity investment with a future option to buy the Seattle company under a May 2 agreement. A feasibility study of Therus' HIFU (high intensity focused ultrasound) technology to close femoral puncture wounds was recently completed, and the firm expects to have a product in Europe in 2003 and in the U.S. by 2004. On April 23, Boston Scientific announced a licensing and equity agreement with SUB-Q for its QuickSeal vascular sealing device (1"The Gray Sheet" April 29, 2002, p. 19). Separately, Boston Scientific announces April 30 that it will take over distribution rights for Onux Medical's Touche tissue fixation suturing products and will help Onux develop technology to treat peptic ulcer disease...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT016495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel